Eli Lilly this week announced plans to sell single-dose vials of its weight loss drug Zepbound directly to consumers. Novo ...

J&J gained rights to the FcRn blocker nipocalimab when it acquired Momenta Pharmaceuticals in August 2020 for $6.5 billion.

In agreeing with Novo Nordisk and Eli Lilly, Pennsylvania judge Karen Spencer Marston said the court should first settle ...

NuCana’s chemotherapy replacement has failed to improve progression-free survival in a Phase II test, sending the biotech’s ...

Despite the added survival benefit for its drug, Alnylam still faces steep competition from Pfizer, whose ATTR-CM therapies ...

The FDA on Thursday expanded Emergent BioSolutions’ smallpox vaccine ACAM2000, allowing its use to prevent mpox infection in individuals deemed at high risk of the disease. ACAM2000’s mpox approval ...

Management Expects Third Quarter 2024 Revenues of at Least $6.5 Million, with a Gross Profit Margin of 52%+ Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 29, 2024) - ...

In Texas, the Plano City Council approved a development agreement that supports a planned project that would bring over 3 ...

BioMarin revealed changes to its C-suite; now, the company has announced its second round of layoffs this year, following the termination of 170 employees in May.

In this episode, the third and final conversation of our mini-series on diversity in clinical trials, Lori and guests discuss framing strategies designed to protect DEI initiatives from legal ...

The chair of the House Committee on Oversight and Accountability wants the CEOs of CVS Caremark, Express Scripts and Optum Rx to fix statements they made in a hearing last month that contradicted the ...

The pharma continued its clinical losing streak on Thursday with the announcement that it is discontinuing late-stage studies ...